Nov 13, 2025 04:29AM Oruka Therapeutics (ORKA) PT Raised to $63 at BTIG

Nov 13, 2025 04:03AM Jefferies Starts Oruka Therapeutics (ORKA) at Buy

Oct 27, 2025 06:49AM Oruka Therapeutics (ORKA) PT Lowered to $40 at H.C. Wainwright

Oct 27, 2025 06:13AM Guggenheim Starts Oruka Therapeutics (ORKA) at Buy

Oct 14, 2025 04:48PM Oruka Therapeutics (ORKA) files for 39.43M share offering by selling stockholders

Oct 14, 2025 04:48PM Oruka Therapeutics (ORKA) files $500M mixed shelf

Oct 13, 2025 05:31AM Barclays Starts Oruka Therapeutics (ORKA) at Overweight

Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'

Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'

Sep 17, 2025 03:37PM Oruka Therapeutics (ORKA) PT Raised to $56 at BTIG

Aug 20, 2025 04:33PM Clear Street Starts Oruka Therapeutics (ORKA) at Buy

Aug 12, 2025 05:04AM BTIG Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Aug 11, 2025 04:48PM Oruka Therapeutics (ORKA) Misses Q2 EPS by 46c

Jul 23, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Jul 21, 2025 08:03AM Stifel Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Jul 1, 2025 04:01PM Oruka Therapeutics (ORKA) Appoints Laura Sandler as COO

May 27, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)

May 22, 2025 06:07AM BTIG Starts Oruka Therapeutics (ORKA) at Buy

May 20, 2025 04:01PM Oruka Therapeutics (ORKA) Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody

May 14, 2025 06:28PM Oruka Therapeutics (ORKA) Misses Q1 EPS by 40c

Mar 7, 2025 07:41AM Stifel Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Mar 6, 2025 05:18PM Oruka Therapeutics (ORKA) Misses Q4 EPS by 49c

Dec 20, 2024 06:52AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Nov 25, 2024 06:45AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Nov 13, 2024 06:01PM Oruka Therapeutics, Inc. (ORKA) Reports Q3 Loss of $1.46

Oct 10, 2024 04:09PM Stifel Starts Oruka Therapeutics (ORKA) at Buy

Oct 7, 2024 12:45PM H.C. Wainwright Starts Oruka Therapeutics (ORKA) at Buy, 'Less (Injections) Is More; Derm Disruption'

Sep 25, 2024 02:03PM TD Cowen Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Sep 25, 2024 07:09AM Oruka Therapeutics (ORKA) Reports Preclinical Data for ORKA-001

Sep 16, 2024 07:12AM LifeSci Capital Starts Oruka Therapeutics (ORKA) at Outperform

Sep 16, 2024 05:31AM TD Cowen Starts Oruka Therapeutics (ORKA) at Buy

Sep 12, 2024 04:47PM Jefferies Starts Oruka Therapeutics (ORKA) at Buy

Sep 12, 2024 07:05AM Oruka Therapeutics (ORKA) Announces $200 Million Private Placement

Sep 12, 2024 07:01AM Oruka Therapeutics (ORKA) Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile